Cargando…
Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid
Aim: Bullous pemphigoid (BP) is an organ-specific autoimmune bullous disease characterized by autoantibodies that target the cellular adhesion molecules BP180 and BP230. Both immunoglobulin (Ig)G and IgE are involved in the induction of subepidermal blisters. Specifically, IgE autoantibodies are pre...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071969/ https://www.ncbi.nlm.nih.gov/pubmed/36999962 http://dx.doi.org/10.1080/07853890.2023.2188487 |